UPCOMING SESSIONS in ET
Wed, Apr 1, 2026
10:00 – 11:00 PM UTC
Facing Fear & Pain in Amyloidosis: How to Take Back Control and Shorten the Storm Cath Jayasuriya Click To Register
UPCOMING SESSIONS in ET
Wed, Apr 1, 2026 · 10:00 – 11:00 PM UTC
Facing Fear & Pain in Amyloidosis: How to Take Back Control and Shorten the Storm
Cath Jayasuriya
Click To Register
View all sessions

Cardiac Amyloidosis - World Heart Federation

Key Information
Source
World Heart Federation
Year
2022
summary/abstract

Amyloidosis is a group of diseases which are characterized by the build-up of abnormal deposits of amyloid fibrils. These amyloid fibrils, composed of misfolded proteins, build up in organs throughout the body. Over time, these amyloid deposits may cause affected organs to stop working properly, which can eventually lead to organ failure.

The two most common types of amyloidosis that affect the heart are light chain amyloidosis (AL) and transthyretin amyloid cardiomyopathy (ATTR-CM). Each type of amyloidosis is characterized by the make-up of the amyloid protein that deposits in the body's organs and tissues. Transthyretin amyloid cardiomyopathy (ATTR-CM) is a presentation of ATTR amyloidosis that primarily affects the heart. Over time, ATTR-CM causes the heart muscle to become stiff, eventually leading to heart failure.

Abstract Source
https://world-heart-federation.org/world-heart-day/cvd-causes-conditions/cardiac-amyloidosis/